Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

NCT00801697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

192

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: DNA Vaccine
BIOLOGICAL: DNA Vaccine placebo
BIOLOGICAL: rAd35
BIOLOGICAL: rAd35 placebo
BIOLOGICAL: rAd5
BIOLOGICAL: rAd5 placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]